drugset / Trial / NCT07334886

A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)

NCT07334886

Phase 1 Completed 8 enrolled Merck Sharp & Dohme LLC
NaSingle-groupOpen-labelBasic science

Summary

The goal of this study is to learn how \[14C\]ulonivirine moves through a healthy person's body over time. Researchers will study how \[14C\]ulonivirine is absorbed by the body, broken down by the body, and how it leaves the body.

Timeline

Start
2025-09-17
Primary completion
2025-11-11
Completion
2025-11-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ulonivirine Small molecule Oral

Indications

No indication recorded.